Pipeline

Pipelines under development

The development of our pipelines is introduced here.​

SBI ALAPharma group's Pipeline

Adaptation level

Main developer

Phase

Investigator initiated

Ischemia reperfusion injury

University of Oxford/  University of Leicester/  University of Birmingham/  University of Cambridge

Combination of aminolevulinic acid hydrochloride and Sodium Ferrous Citrate
Phase II

Sponsor initiated

Photodynamic diagnosis of breast cancer

In-house

 

Aminolevulinic acid hydrochloride
Phase III

Sponsor initiated

Photodynamic diagnosis of ovarian cancer

In-house

Aminolevulinic acid hydrochloride
Phase III

Sponsor initiated

Photodynamic diagnosis of meningioma

In-house

Aminolevulinic acid hydrochloride
Phase III

Investigator initiated

Interstitial photodynamic therapy for recurrent malignant glioma

University Hospital Münster

 

Aminolevulinic acid hydrochloride
Phase IIb

Sponsor initiated

Interstitial photodynamic therapy for primary malignant glioma

In-house

Aminolevulinic acid hydrochloride
Phase I/II

Investigator initiated

Radiodynamic therapy for recurrent malignant glioma

University Hospital Münster

 

Aminolevulinic acid hydrochloride
Phase II
Ischemia reperfusion injury
Phase II
Photodynamic diagnosis of breast cancer
Phase III
Photodynamic diagnosis of ovarian cancer
Phase III
Photodynamic diagnosis of meningioma
Phase III
Interstitial photodynamic therapy for recurrent malignant glioma
Phase IIb
Interstitial photodynamic therapy for primary malignant glioma
Phase I/II
Radiodynamic therapy for recurrent malignant glioma
Phase II
Mechanical Translations by Google »